Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating
Daniel I. Brierley, Guillaume de Lartigue
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 584-599
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Signaling pathways in obesity: mechanisms and therapeutic interventions
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 244
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Jens J. Holst
Nature Metabolism (2024) Vol. 6, Iss. 10, pp. 1866-1885
Open Access | Times Cited: 21
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Malignant Tumors in Vagal-innervated Organs: Exploring Its Homeostatic Role
Pierrick Martinez, Jean‐Marc Sabatier
Cancer Letters (2025), pp. 217539-217539
Closed Access | Times Cited: 2
Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
Stefan Trapp, Daniel I. Brierley
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 557-570
Open Access | Times Cited: 87
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node
Anniek F. Lubberding, Simon Veedfald, Jonathan Samuel Achter, et al.
Cardiovascular Research (2024)
Open Access | Times Cited: 8
Are glucagon-like peptide-1 receptor agonists anti-consummatory drugs?
Rodrigo B. Mansur, Joshua D. Di Vincenzo, Sebastian Badulescu, et al.
CNS Spectrums (2025), pp. 1-6
Closed Access | Times Cited: 1
Enteroendocrine cell regulation of the gut-brain axis
Joshua R. Barton, Anne Londregan, Tyler D. Alexander, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
Central and peripheral actions of nicotine that influence blood glucose homeostasis and the development of diabetes
Zuxin Chen, Xin‐an Liu, Paul J. Kenny
Pharmacological Research (2023) Vol. 194, pp. 106860-106860
Open Access | Times Cited: 16
G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?
Mohan Patil, Ilaria Casari, Leon N. Warne, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116245-116245
Open Access | Times Cited: 5
Seeking satiety: From signals to solutions
Matthias H. Tschöp, Jeffrey M. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 723
Closed Access | Times Cited: 12
Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease
Ides M. Colin, Lidia W Szczepanski, A Gérard, et al.
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 16-16
Open Access | Times Cited: 11
GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation
Maedeh Movahednasab, Hassan Dianat‐Moghadam, Sana Khodadad, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Vagal Sensory Gut–Brain Pathways That Control Eating—Satiety and Beyond
Rebeca Méndez‐Hernández, Isadora Braga, Avnika Bali, et al.
Comprehensive physiology (2025) Vol. 15, Iss. 2
Closed Access
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Claudio E. Perez‐Leighton, Bredford Kerr, Philipp E. Scherer, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2023) Vol. 99, Iss. 3, pp. 653-674
Closed Access | Times Cited: 9
Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite
Hayley E. McMorrow, Carolyn M. Lorch, Nikolas W. Hayes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Glucagon‐like peptide‐1: Are its roles as endogenous hormone and therapeutic wizard congruent?
Jens J. Holst
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 557-573
Closed Access | Times Cited: 14
Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture
Jens J. Holst
Diabetes (2021) Vol. 70, Iss. 11, pp. 2468-2475
Open Access | Times Cited: 19
GLP-1 – Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy
Jens J. Holst, Sara L. Jepsen, Ida M. Modvig
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102189-102189
Open Access | Times Cited: 13
Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem
Dhanush Haspula, Zhenzhong Cui
Cells (2023) Vol. 12, Iss. 13, pp. 1801-1801
Open Access | Times Cited: 7
New developments in the prospects for GLP‐1 therapy
Stefan Trapp, S. Clare Stanford
British Journal of Pharmacology (2022) Vol. 179, Iss. 4, pp. 489-491
Open Access | Times Cited: 11
Discovery of the GI Effects of GLP-1: An Historical Perspective
Jens J. Holst
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 7, pp. 2716-2720
Closed Access | Times Cited: 11
The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues
Leah A. Peart, Matthew Draper, Andrei I. Tarasov
Peptides (2024) Vol. 178, pp. 171243-171243
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top